HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Elisabeth Luthringer Selected Research

roluperidone

1/2022Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia.
12/2017Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Elisabeth Luthringer Research Topics

Disease

2Schizophrenia (Dementia Praecox)
01/2022 - 12/2017

Drug/Important Bio-Agent (IBA)

2roluperidoneIBA
01/2022 - 12/2017
1Dopamine (Intropin)FDA LinkGeneric
12/2017
1Pharmaceutical PreparationsIBA
12/2017